Democratizing complex cardiac and brain stroke interventions with AI-driven mini-robotics

At Carvolix, we are transforming cardiac valve replacement and ischemic stroke treatment. We focus on conditions with large unmet clinical need and limited patient access to effective therapy.

Discover Our Solutions
About Carvolix

17%

of the 1.7 million patients eligible for TAVI undergo treatment

4%

of the 4 million patients with severe mitral regurgitation undergo surgery

<5%

of eligible ischemic stroke patients worldwide have access to mechanical thrombectomy

Our Portfolio

At Carvolix, we are transforming cardiac valve replacement and ischemic stroke treatment.

Carvolix develops AI- and imaging-driven mini-robotic technologies designed to expand access to these life-saving procedures. Our platform supports interventional cardiologists in complex procedures, where precision, consistency, and speed are critical.

Our mini-robots operate with supervised autonomy, guided by real-time imaging and artificial intelligence. By assisting with navigation and positioning, they help clinicians manage the most technically demanding steps of valve and stroke interventions, with the goal of improving procedural efficiency, safety, and patient outcomes.

By empowering interventional cardiologists, far more numerous than surgeons and interventional neuroradiologists, and highly receptive to innovation, we expand patients’ access to advanced procedures. Our platform enables a broader base of physicians to perform complex interventions with greater precision, confidence, and reproducibility, ultimately accelerating patient access to life-saving therapies.

Discover our Solutions